Skip to main content

Susana Gómez Olles

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Susana Gómez Olles

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

BIOMARCADORES NO INVASIVOS DE DISFUNCIÓN CRÓNICA EN TRASPLANTE PULMONAR.

IP: Cristina Berastegui Garcia
Collaborators: Carles Bravo Masgoret, Eva Maria Revilla Lopez, Meritxell Boada Perez, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 117370
Reference: PI22/01103
Duration: 01/01/2023 - 31/12/2025

Grup de Recerca en Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Sergi Martí Beltran, Marta Vicenta Arjona Perís, Christian Eduardo Romero Mesones, Maria Angeles Jiménez Fuentes, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Álvarez Fernandez, Victor Monforte Torres, Odile Romero Santo-Tomas, Miriam Barrecheguren Fernández, David Clofent Alarcón, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Almudena Felipe Montiel, Eva Maria Revilla Lopez, Gerard Orriols Torras, Julia Sampol Sirvent, Meritxell Boada Perez, David Espejo Castellanos, Manuel López Meseguer, David Soler Segovia, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino, Letizia Traversi
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00788
Duration: 01/01/2022 - 31/12/2024

Functional Immune-Monitoring of Virus-specific T and B-cell Responses in Solid Organ Transplant. Recipients receiving SARS-CoV-2 Vaccination (MoniToR)

IP: Susana Gómez Olles
Collaborators: -
Funding agency: Fundació La Marató de TV3
Funding: 195790.4
Reference: 1059/U/2021
Duration: 20/10/2021 - 20/10/2023

Partida para intensificació durant la 2a i 3a anualitat

IP: Susana Gómez Olles
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 60000
Reference: PI18/00035_INT_BERASTEGUI
Duration: 01/01/2020 - 30/06/2023

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Francisca Gallego Valades

Francisca Gallego Valades

Administration and Management
Read more
Marc Pellicer Sarasa

Marc Pellicer Sarasa

Biomedical Research in Cancer Stem Cells
Read more
Nuria Laia Rodriguez Mias

Nuria Laia Rodriguez Mias

Read more
Anna  Abuli  Vidal

Anna Abuli Vidal

Postdoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.